Yıl: 2018 Cilt: 1 Sayı: 1 Sayfa Aralığı: 1 - 9 Metin Dili: Türkçe DOI: 10.5336/jtracom.2017-54818 İndeks Tarihi: 06-03-2020

Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu

Öz:
Amaç: Kronik hastalığı olan bireylerin daha uzun ve sağlıklı yaşama isteği, tamamlayıcı vealternatif tıp (TAT) yöntemlerine yönelmelerine neden olmaktadır. Bu çalışma, kronik hastalığıolan bireylerin TAT kullanma durumunu incelemek amacıyla tanımlayıcı olarak yapılmıştır. Gereçve Yöntemler: Araştırmaya Nisan 2016-Temmuz 2016 tarihleri arasında bir üniversite hastanesinindâhiliye polikliniklerine başvuran ve çalışma kriterlerine uyan 207 hasta alındı. Literatür taranarakoluşturulan veri toplama aracı, yüz yüze görüşme yöntemi kullanılarak uygulandı. Bulgular: Araştırmakapsamına alınan hastaların %62,3’ünün TAT yöntemlerini kullandığı ve en sık bitkisel ürünleri(%58,5), daha az oranda vitamin desteği (%7,7), masaj (%4,8) ve aromaterapi (%4,8) tercih ettiğisaptanmıştır. Hastalar TAT yöntemlerini tansiyonu düşürmek (%38,8), ağrıyı gidermek (%30,2),enfeksiyonu tedavi etmek (%13,2), kan şekerini düşürmek (%9,3) ve kanseri iyileştirmek (%6,2)amacıyla kullanmakta ve sağlığına olumlu etkisi olduğunu düşünmektedir. Sonuç: Kronik hastalığıolan bireylerin yarıdan fazlasının TAT yöntemlerini kullandığı ve kolay ulaşılabilir yöntemlerdenbiri olan bitkisel ürünleri tercih ettiği belirlenmiştir. Bu doğrultuda hemşireler, bireylerin hastalığınyönetimine ilişkin yaşadıkları sorunları ve herhangi bir TAT yöntemi kullanıp kullanmadıklarınıve hasta için bu yöntemin uygunluğunu değerlendirmelidir.
Anahtar Kelime:

Konular: Hemşirelik

Status of Using Complementary and Alternative Treatments of Individuals with Chronic Disease

Öz:
Objective: For a longer and healthier life, individuals with chronic illnesses tend to prefer complementary and alternative medicine (CAM) methods. This descriptive study investigates the use of CAM by these individuals. Material and Methods: 207 patients admitted to the internal medicine clinics of a university hospital in April-July 2016 and complying with the criteria were included in the study. The data collection tool created through reviewing the literature was applied using a face-to-face interview method. Results: We found that overall 62.3% of respondents had used CAM and they mostly preferred herbal products (58.5%), lesser extent vitamin supplements (7.7%), massage (4.8%) and aromatherapy (4.8%). CAM was used to lower blood pressure (38.8%), relieve pain (30.2%), treatment of infections (13.2%), lowering of blood sugar (9.3%) and improvement of cancer (6.2%) and patients thought "positive effect on your health’’. Conclusion: It was determined that more than half of the individuals with chronic disease used CAM methods and they preferred herbal products which are one of the easily accessible methods. Nurses must evaluate that individuals have experienced problems regarding the management of the disease and whether they uses any CAM method and the suitability of this method for the patient.
Anahtar Kelime:

Konular: Hemşirelik
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Özçelik G, Toprak D. Why is phytotherapy preferred? Ankara Med J 2015;15(2):48-58.
  • 2. GözümS, Unsal A. Use of herbal therapies by older, communitydwelling women. J Adv Nurs 2004;46(2):171-8.
  • 3. Arthur K, Belliard JC, Hardin SB, Knecht K, Chen CS, Montgomery S. Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients. Integr Cancer Ther 2012;11(3):232-42.
  • 4. Ben-Arye E, Frenkel M. Referring to complementary and alternative medicine--a possible tool for implementation. Complement Ther Med 2008;16(6):325-30.
  • 5. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and Alternative Medicine Use Among Adults: United States, 2002. Advance Data From Vital and Health Statistics; No 343. Hyattsville, MD: National Center for Health Statistics; 2004. p.20.
  • 6. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the Use of Complementary Health Approaches Among Adults: United States, 2002-2012. National Health Statistics Reports; No 79. National Center for Health Statistics; Hyattsville, MD: DHHS publication; 2015. p.15.
  • 7. Güven ŞD, Muz G, Efe Ertürk N, Özcan A. [Use of complementary and alternative treatment in the patients with hypertension]. Balıkesir Health Sciences Journal 2013;2(3): 160-6.
  • 8. TokemY. [The use of complementary and alternative treatment in patients with asthma]. Tüber-küloz ve Toraks Dergisi 2006;54(2):189-96.
  • 9. Kav S, Hanoğlu Z, Algier L. [Use of complementary and alternativemedicine by cancer patients in Turkey: a literature review]. International Journal ofHematology andOncology 2008;18(1):32-8.
  • 10. Tas F, Ustuner Z, Can G, Eralp Y, Camlica H, Basaran M, et al. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol 2005;44(2):161-7.
  • 11. Ching SM, Zakaria ZA, Paimin F, Jalalian M. Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complement Altern Med 2013;13:148.
  • 12. Gözüm S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs 2003;26(3):230-6.
  • 13. Hasan SS, Ahmed SI, Bukhari NI, Loon WC. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract 2009;15(3):152-7.
  • 14. Ulusoy H, Kaya Güçer T, AksuM, Arslan Ş, Habiboğlu A, Akgöl G, et al. The use of complementary and alternative medicine in Turkish patients with rheumatic diseases. Turk J Rheumatol 2012;27(1):31-7.
  • 15. Yarney J, Donkor A, Opoku SY, Yarney L, Agyeman-Duah I, Abakah AC, et al. Characteristics of users and implications for the use of complementary and alternativemedicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross-sectional study. BMCComplement AlternMed 2013;13:16.
  • 16. Uysal H. [Current approaches to complementary and alternative medicine in cardiovascular diseases]. Journal of Cardiovascular Nursing 2016;7(Suppl 2):69-83.
  • 17. Complementary, Alternative, or Integrative Health: What’s In a Name? https://nccih.nih. gov/health/integrative-health. Erişim Tarihi: 1.03.2017.
  • 18. Resmi Gazete (29.5.1991; Sayı: 20885) Akupunktur Tedavi Yönetmeliği. 1991. p.3.
  • 19. Mollahaliloğlu S, Uğurlu FG, KalaycıMZ, Öztaş D. [The new period in traditional and complementary medicine]. Ankara Med J 2015;15(2):102-5.
  • 20. Erdoğan Z, Oğuz S, Erol E. [Use of complementary therapies in the patients with heart disease]. Spatula DD 2012;2(3):135-9.
  • 21. Akyuz A, Dede M, Cetinturk A, Yavan T, Yenen MC, Sarici SU, et al. Self-application of complementary and alternative medicine by patients with gynecologic cancer. Gynecol Obstet Invest 2007;64(2):75-81.
  • 22. Basak T, Unver V, Demirkaya S. The use of complementary and alternativemedicine bymultiple sclerosis patients in Turkey. Gulhane Med J 2014;56(2):71-5.
  • 23. Malak AT, KarayurtO, Demir E, Yümer AS. Complementary and alternative medicine in cancer patients-analysis of influencing factors in Turkey. Asian Pac J Cancer Prev 2009;10(6):1083-7.
  • 24. Ali-ShtayehMS, Jamous RM, Jamous RM. Complementary and alternative medicine use amongst Palestinian diabetic patients. Complement Ther Clin Pract 2012;18(1):16-21.
  • 25. Uğurluer G, Karahan A, Edirne, T, Şahin HA. [The prevalence and causes of the use of complementary and alternative medicine in patients treated at an outpatient chemotherapy unit]. Van Med J 2007;14(3):68-73.
  • 26. Lafçı D, Kaşıkçı MK. [The knowledge level and using of complementary and alternative therapies of the health personal who working at hospitals]. Gümüşhane University Journal of Health Sciences 2014;3(4):1-18.
  • 27. Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 2004;12(2):90-8.
  • 28. Lee GB, Charn TC, Chew ZH, Ng TP. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 2004;21(6):654-60.
  • 29. Algier LA, Hanoglu Z, Ozden G, Kara F. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. Eur J Oncol Nurs 2005;9(2):138-46.
  • 30. Öğüt Düzen K, Korkmaz M. [Symptom control in cancer patients, and use of complementary and alternative medicine]. DEUHFED 2015;8(2):67-76.
  • 31. Dişsiz G, Yilmaz M. Complementary and alternative therapies and health literacy in cancer patients. Complement Ther Clin Pract 2016;23:34-9.
  • 32. Erdoğan Z, Çınar S, Şimşek S. [The relationship between hopelessness level and the use of complementary medicine methods in hemodialysis patients]. Spatula DD 2013;3(3):107-12.
  • 33. Farooqui M, Hassali MA, Shatar AK, Farooqui MA, Saleem F, Haq NU, et al. Use of complementary and alternativemedicines among Malaysian cancer patients: a descriptive study. J Tradit Complement Med 2016;6(4):321-6.
  • 34. Kretchy IA, Owusu-Daaku F, Danquah S. Patterns and determinants of the use of complementary and alternative medicine: a cross-sectional study of hypertensive patients in Ghana. BMC Complement Altern Med 2014;14:44.
  • 35. YehGY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006;98(5):673-80.
  • 36. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. CAM use among older adults age 65 or older with hypertension in the United States: general use and disease treatment. J Altern Complement Med 2006;12(9): 903-9.
  • 37. Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med 2015;13(5):319-25.
  • 38. Manya K, Champion B, Dunning T. The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med 2012;12:2.
  • 39. Huebner J, Micke O, Muecke R, Buentzel J, Prott FJ, Kleeberg U, et al; PRIO (Working Group Prevention and Integrative Oncology of the German Cancer Society). User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res 2014;34(2):943-8.
  • 40. Hori S, Mihaylov I, Vasconcelos JC, McCoubrie M. Patterns of complementary and alternative medicine use amongst outpatients in Tokyo, Japan. BMC Complement Altern Med 2008;8:14.
  • 41. Foltz V, St Pierre Y, Rozenberg S, Rossignol M, Bourgeois P, Joseph L, et al. Use of complementary and alternative therapies by patients with self-reported chronic back pain: a nationwide survey in Canada. Joint Bone Spine 2005;72(6):571-7.
  • 42. Wazaify M, Alawwa I, Yasein N, Al-Saleh A, Afifi FU. Complementary and alternative medicine (CAM) use among Jordanian patients with chronic diseases. Complement Ther Clin Pract 2013;19(3):153-7.
  • 43. Wood MJ, Stewart RL, Merry H, Johnstone DE, Cox JL. Use of complementary and alternativemedical therapies in patients with cardiovascular disease. Am Heart J 2003;145(5):806-12.
  • 44. Metcalfe A, Williams J, McChesney J, Patten SB, Jetté N. Use of complementary and alternative medicine by those with a chronic disease and the general population--results of a national population based survey. BMC Complement Altern Med 2010;10:58.
  • 45. Gor A, Kothari N, Shah P, Gaur K. Use of complementary and alternative medicine (CAM) in patients with essential hypertension and diabetesmellitus attending a tertiary care teaching hospital. Inter J Med Sci Dent Heal 2015;1(2):50-7.
  • 46. Osamor PE, Owumi BE. Complementary and alternative medicine in the management of hypertension in an urban Nigerian community. BMC Complement Altern Med 2010;10:36.
  • 47. Efe D, Kılıç Akça N, Kiper S, Aydın G, Gümüş K. [Supportive methods used by the individuals with hypertension to decrease blood pressure]. Spatula DD 2012;2(4):207-12.
  • 48. Pledger MJ, Cumming J, Burnette M. Health service use amongst users of complementary and alternativemedicine. The New Zealand Medical Journal 2010;123(1312):26-35.
  • 49. Arcury TA, Bell RA, Snively BM, Smith SL, Skelly AH, Wetmore LK, et al. Complementary and alternativemedicine use as health self-management: rural older adults with diabetes. J Gerontol B Psychol Sci Soc Sci 2006;61(2):62-70.
  • 50. Meurk C, Broom A, Adams J, Sibbritt D. Rurality, mobility, identity: women’s use of complementary and alternativemedicine in rural Australia. Health Place 2013;20:75-80.
  • 51. Posadzki P, Watson LK, Ernst E. Adverse effects of herbalmedicines: an overview of systematic reviews. Clin Med (Lond) 2013;13(1):7-12.
  • 52. Oxelmark L, Lindberg A, Löfberg R, Sternby B, Eriksson A, Almer S, et al; SOIBD, the Swedish Organization for the study of Inflammatory Bowel Disease. Use of complementary and alternativemedicine in Swedish patients with inflammatory bowel disease: a controlled study. Eur J Gastroenterol Hepatol 2016;28(11):1320-8.
  • 53. Araz A, Harlak H, Meşe G. [Health behaviors and alternative medicine use]. TSK Koruyucu Hekimlik Bülteni 2007;6(2):112- 22.
  • 54. Polat G. [Evaluation of newspaper articles about complementary alternative medicine in terms of journalism, public health and medical ethics]. International Journal of Human Sciences 2014;11(1):814-35.
  • 55. Molassiotis A, Scott JA, Kearney N, Pud D, Magri M, Selvekerova S, et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 2006;14(3):260-7.
APA NURAL N, Çakmak S (2018). Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. , 1 - 9. 10.5336/jtracom.2017-54818
Chicago NURAL NESRİN,Çakmak Seher Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. (2018): 1 - 9. 10.5336/jtracom.2017-54818
MLA NURAL NESRİN,Çakmak Seher Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. , 2018, ss.1 - 9. 10.5336/jtracom.2017-54818
AMA NURAL N,Çakmak S Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. . 2018; 1 - 9. 10.5336/jtracom.2017-54818
Vancouver NURAL N,Çakmak S Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. . 2018; 1 - 9. 10.5336/jtracom.2017-54818
IEEE NURAL N,Çakmak S "Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu." , ss.1 - 9, 2018. 10.5336/jtracom.2017-54818
ISNAD NURAL, NESRİN - Çakmak, Seher. "Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu". (2018), 1-9. https://doi.org/10.5336/jtracom.2017-54818
APA NURAL N, Çakmak S (2018). Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. Geleneksel ve Tamamlayıcı Tıp Dergisi, 1(1), 1 - 9. 10.5336/jtracom.2017-54818
Chicago NURAL NESRİN,Çakmak Seher Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. Geleneksel ve Tamamlayıcı Tıp Dergisi 1, no.1 (2018): 1 - 9. 10.5336/jtracom.2017-54818
MLA NURAL NESRİN,Çakmak Seher Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. Geleneksel ve Tamamlayıcı Tıp Dergisi, vol.1, no.1, 2018, ss.1 - 9. 10.5336/jtracom.2017-54818
AMA NURAL N,Çakmak S Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. Geleneksel ve Tamamlayıcı Tıp Dergisi. 2018; 1(1): 1 - 9. 10.5336/jtracom.2017-54818
Vancouver NURAL N,Çakmak S Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. Geleneksel ve Tamamlayıcı Tıp Dergisi. 2018; 1(1): 1 - 9. 10.5336/jtracom.2017-54818
IEEE NURAL N,Çakmak S "Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu." Geleneksel ve Tamamlayıcı Tıp Dergisi, 1, ss.1 - 9, 2018. 10.5336/jtracom.2017-54818
ISNAD NURAL, NESRİN - Çakmak, Seher. "Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu". Geleneksel ve Tamamlayıcı Tıp Dergisi 1/1 (2018), 1-9. https://doi.org/10.5336/jtracom.2017-54818